stars 1 stars 2 stars 3

Refocus Group, Inc. is a medical device company engaged in the research and development of treatments for human vision disorders. Our mission is to become the surgical standard of care for presbyopia. Refocus Group's latest product is the VisAbility™ Implant System, which is used in an innovative procedure known as the VisAbility™ Procedure. The implant is an investigational device and is not yet approved for sale or use in the United States or Canada. However, the product is currently approved for sale in the European Union.

Refocus Group, Inc. Questions

The Refocus Group, Inc. annual revenue was $5 million in 2026.

Dave Ozinga is the Vice President of Manufacturing Operations of Refocus Group, Inc..

2 people are employed at Refocus Group, Inc..

Refocus Group, Inc. is based in Dallas, Texas.

The NAICS codes for Refocus Group, Inc. are [54, 541, 33].

The SIC codes for Refocus Group, Inc. are [38, 384].

Top Refocus Group, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users